Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

[Medullary thyroid carcinoma in children].

Berdelou A, Hartl D, Al Ghuzlan A, Mirghani H, Chougnet C, Baudin E, Schlumberger M, Leboulleux S.

Bull Cancer. 2013 Jul-Aug;100(7-8):780-8. doi: 10.1684/bdc.2013.1775. Review. French.

PMID:
23831771
2.

Diagnosis and treatment of medullary thyroid cancer.

Modigliani E, Franc B, Niccoli-sire P.

Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Dec;14(4):631-49. Review.

PMID:
11289739
3.

Medullary thyroid carcinoma.

Pacini F, Castagna MG, Cipri C, Schlumberger M.

Clin Oncol (R Coll Radiol). 2010 Aug;22(6):475-85. doi: 10.1016/j.clon.2010.05.002. Review.

PMID:
20627492
4.

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.

Cancer. 2002 Jan 15;94(2):323-30.

5.

Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.

Moers AM, Landsvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Höppener JW, Vroom TM, van Amstel HK, Lips CJ.

Am J Med. 1996 Dec;101(6):635-41.

PMID:
9003111
6.

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.

Marsh DJ, Mulligan LM, Eng C.

Horm Res. 1997;47(4-6):168-78. Review.

PMID:
9167949
7.

Medullary thyroid carcinoma in children.

Viola D, Romei C, Elisei R.

Endocr Dev. 2014;26:202-13. doi: 10.1159/000363165. Epub 2014 Aug 29. Review.

PMID:
25231454
8.

[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].

Fitze G, Saeger HD, Roesner D, Schackert HK.

Klin Padiatr. 2004 Sep-Oct;216(5):270-6. German.

PMID:
15455293
9.

Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.

Skinner MA, Wells SA Jr.

Semin Pediatr Surg. 1997 Aug;6(3):134-40. Review.

PMID:
9263335
10.

Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.

Vieira AE, Mello MP, Elias LL, Lau IF, Maciel LM, Moreira AC, Castro M.

Horm Metab Res. 2002 Apr;34(4):202-6.

PMID:
11987030
11.

Advances and controversies in the diagnosis and management of medullary thyroid carcinoma.

Heshmati HM, Gharib H, van Heerden JA, Sizemore GW.

Am J Med. 1997 Jul;103(1):60-9. Review.

PMID:
9236487
12.

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].

Sansó G, Domené HM, Iorcansky S, Barontini M.

Medicina (B Aires). 1998;58(2):179-84. Spanish.

PMID:
9706252
13.

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.

Krampitz GW, Norton JA.

Cancer. 2014 Jul 1;120(13):1920-31. doi: 10.1002/cncr.28661. Epub 2014 Apr 3. Review.

14.

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Wells SA Jr, Pacini F, Robinson BG, Santoro M.

J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6. Review.

15.

Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.

Allen SM, Bodenner D, Suen JY, Richter GT.

Laryngoscope. 2009 Jul;119(7):1303-11. doi: 10.1002/lary.20299. Review.

PMID:
19444888
16.

[Multiple endocrine neoplasia syndromes. Type 2].

Juodele L, Juozaityte E, Zindzius A, Pundzius J.

Medicina (Kaunas). 2005;41(4):281-94. Review. Lithuanian.

17.

Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.

Boikos SA, Stratakis CA.

Histol Histopathol. 2008 Jan;23(1):109-16. doi: 10.14670/HH-23.109. Review.

PMID:
17952863
18.

A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.

Chiefari E, Chiarella R, Crocetti U, Tardio B, Arturi F, Russo D, Trischitta V, Filetti S, Zingrillo M.

Horm Metab Res. 2001 Jan;33(1):52-6.

PMID:
11280716
19.
20.

Management of medullary thyroid carcinoma.

Jiménez C, Hu MI, Gagel RF.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):481-96, x-xi. doi: 10.1016/j.ecl.2008.03.001. Review.

PMID:
18502338

Supplemental Content

Support Center